174 related articles for article (PubMed ID: 20069086)
1. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.
Thomas JE; Munir JA; McIntyre PZ; Ferguson MA
Tex Heart Inst J; 2009; 36(6):586-90. PubMed ID: 20069086
[TBL] [Abstract][Full Text] [Related]
2. Coronary thrombosis related to use of Xenadrine RFA.
Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
[TBL] [Abstract][Full Text] [Related]
3. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.
Bouchard NC; Howland MA; Greller HA; Hoffman RS; Nelson LS
Mayo Clin Proc; 2005 Apr; 80(4):541-5. PubMed ID: 15819293
[TBL] [Abstract][Full Text] [Related]
4. Lack of evidence that p-synephrine is responsible for STEMI.
Stohs SJ
Tex Heart Inst J; 2010; 37(3):383; author reply 383-4. PubMed ID: 20548833
[No Abstract] [Full Text] [Related]
5. Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium.
Smith TB; Staub BA; Natarajan GM; Lasorda DM; Poornima IG
Tex Heart Inst J; 2014 Feb; 41(1):70-2. PubMed ID: 24512406
[TBL] [Abstract][Full Text] [Related]
6. [Risk assessment of synephrine in dietary supplements].
Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
[TBL] [Abstract][Full Text] [Related]
7. Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female.
Chung H; Kwon SW; Kim TH; Yoon JH; Ma DW; Park YM; Hong BK
Korean J Intern Med; 2013 May; 28(3):356-60. PubMed ID: 23682231
[TBL] [Abstract][Full Text] [Related]
8. A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement.
Burke J; Seda G; Allen D; Knee TS
Mil Med; 2007 Jun; 172(6):656-8. PubMed ID: 17615852
[TBL] [Abstract][Full Text] [Related]
9. Ventricular fibrillation associated with use of synephrine containing dietary supplement.
Stephensen TA; Sarlay R
Mil Med; 2009 Dec; 174(12):1313-9. PubMed ID: 20055074
[TBL] [Abstract][Full Text] [Related]
10. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
Nykamp DL; Fackih MN; Compton AL
Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
[TBL] [Abstract][Full Text] [Related]
11. Vasospasm and stroke attributable to ephedra-free xenadrine: case report.
Holmes RO; Tavee J
Mil Med; 2008 Jul; 173(7):708-10. PubMed ID: 18700609
[TBL] [Abstract][Full Text] [Related]
12. "Ephedra-free" diet pill-induced psychosis.
Retamero C; Rivera T; Murphy K
Psychosomatics; 2011; 52(6):579-82. PubMed ID: 22054631
[No Abstract] [Full Text] [Related]
13. STEMI in a Young Male after Use of Synephrine-Containing Dietary Supplement.
Unnikrishnan D; Annam R; Jacob A; Thyagarajan B; Farrugia P
Case Rep Cardiol; 2018; 2018():7074104. PubMed ID: 29808122
[TBL] [Abstract][Full Text] [Related]
14. Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine.
Smedema JP; Müller GJ
S Afr Med J; 2008 May; 98(5):372-3. PubMed ID: 18637307
[No Abstract] [Full Text] [Related]
15. Multiple coronary artery thrombosis in a 41-year-old male patient presenting with ST-segment elevation myocardial infarction.
Al Suwaidi J; Al-Qahtani A
J Invasive Cardiol; 2012 Mar; 24(3):E43-6. PubMed ID: 22388313
[TBL] [Abstract][Full Text] [Related]
16. Review of Case Reports on Adverse Events Related to Pre-workout Supplements Containing Synephrine.
de Jonge MLL; Kieviet LC; Sierts M; Egberink LB; van der Heyden MAG
Cardiovasc Toxicol; 2023 Jan; 23(1):1-9. PubMed ID: 36639595
[TBL] [Abstract][Full Text] [Related]
17. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
[TBL] [Abstract][Full Text] [Related]
18. Impact of thrombus aspiration use and direct stenting on final myocardial blush score in patients presenting with ST-elevation myocardial infarction.
Lemesle G; Sudre A; Bouallal R; Delhaye C; Rosey G; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2010; 11(3):149-54. PubMed ID: 20599164
[TBL] [Abstract][Full Text] [Related]
19. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention.
Sianos G; Papafaklis MI; Serruys PW
J Invasive Cardiol; 2010 Oct; 22(10 Suppl B):6B-14B. PubMed ID: 20947930
[TBL] [Abstract][Full Text] [Related]
20. Double coronary artery thrombosis presenting as acute extensive anterior ST-segment elevation myocardial infarction.
Lee CW; Lai CH; Lu TM
J Chin Med Assoc; 2013 Jul; 76(7):407-10. PubMed ID: 23664732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
